Kyung Won Lee
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Kyung Won Lee has a total of 41 co-authors. Here are the top co-authors by number of shared publications:
- Jihang Kim
Department of Radiology, Seoul National University Bundang Hospital, Seongnam, Republic of Korea
5 shared publications - Jin-Haeng Chung
Department of Pathology, Seoul National University College of Medicine, Seoul, Korea
4 shared publications - Junghoon Kim
Department of Radiology, Seoul National University Bundang Hospital, Seongnam, Republic of Korea
4 shared publications - Yeon Wook Kim
Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, Republic of Korea
3 shared publications Choon-Taek Lee
Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea; Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, Republic of Korea
2 shared publications- Choon-Taek Lee
Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Seoul National University College of Medicine Seoul National University Bundang Hospital 82, Gumi‐ro 173 Beon‐gil, Bundang‐gu Seongnam‐si Gyeonggi‐do 13620 Republic of Korea
2 shared publications
Latest Publications
- Open Access
- 1 November 2026
- Published by Elsevier in Lung Cancer
- Vol. 222
Radiologic phenotype and the size dependence of adverse histologic features and recurrence in resected lung adenocarcinoma
- 1 November 2026
- Published by Elsevier in Lung Cancer
- Vol. 222
Open AccessRadiologic phenotype and the size dependence of adverse histologic features and recurrence in resected lung adenocarcinoma
- 4 March 2025
- Published by Elsevier in Journal of the American College of Radiology
- Vol. 22 (6) , 633-643
Visual Emphysema as a Category Modifier in Lung-RADS Using a Secondary Analysis of National Lung Screening Trial
- 4 March 2025
- Published by Elsevier in Journal of the American College of Radiology
- Vol. 22 (6) , 633-643
Visual Emphysema as a Category Modifier in Lung-RADS Using a Secondary Analysis of National Lung Screening Trial
- Open Access
- 1 December 2021
- Published by AME Publishing Company in Translational Lung Cancer Research
- Vol. 10 (11) , 4185-4199
Differences in detection patterns, characteristics, and outcomes of central and peripheral lung cancers in low-dose computed tomography screening
Differences in detection patterns, characteristics, and outcomes of central and peripheral lung cancers in low-dose computed tomography screening Yeon Wook Kim, Minhee Jeon, Myung Jin Song, Byoung Soo Kwon, Sung Yoon Lim, Yeon Joo Lee, Jong Sun Park, Young-Jae Cho, Ho Il Yoon, Kyung Won Lee, Jae Ho Lee, Choon-Taek Lee
- 1 December 2021
- Published by AME Publishing Company in Translational Lung Cancer Research
- Vol. 10 (11) , 4185-4199
Open AccessDifferences in detection patterns, characteristics, and outcomes of central and peripheral lung cancers in low-dose computed tomography screening
Differences in detection patterns, characteristics, and outcomes of central and peripheral lung cancers in low-dose computed tomography screening Yeon Wook Kim, Minhee Jeon, Myung Jin Song, Byoung Soo Kwon, Sung Yoon Lim, Yeon Joo Lee, Jong Sun Park, Young-Jae Cho, Ho Il Yoon, Kyung Won Lee, Jae Ho Lee, Choon-Taek Lee
- 1 August 2021
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 300 (2) , 450-457
Application of N Descriptors Proposed by the International Association for the Study of Lung Cancer in Clinical Staging
Stratification of clinical N2 disease by the number of stations involved can reduce prognostic heterogeneity by identifying the two patient groups with different prognoses. Background Patients with N1 or N2 non–small cell lung cancer exhibit prognostic heterogeneity. To refine the current N staging system, new N stages were proposed by the International Association fo...
- 1 August 2021
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 300 (2) , 450-457
Application of N Descriptors Proposed by the International Association for the Study of Lung Cancer in Clinical Staging
Stratification of clinical N2 disease by the number of stations involved can reduce prognostic heterogeneity by identifying the two patient groups with different prognoses. Background Patients with N1 or N2 non–small cell lung cancer exhibit prognostic heterogeneity. To refine the current N staging system, new N stages were proposed by the International Association fo...
- 1 September 2020
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 296 (3) , 652-661
Deep Learning–based Automatic Detection Algorithm for Reducing Overlooked Lung Cancers on Chest Radiographs
Chest radiograph interpretation, assisted by a deep learning–based automatic detection algorithm, can reduce the number of overlooked lung cancers without increasing the frequency of chest CT follo... Background It is uncertain whether a deep learning–based automatic detection algorithm (DLAD) for identifying malignant nodules on chest radiographs will help diagnose lung cancers. Purpose To eval...
- 1 September 2020
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 296 (3) , 652-661
Deep Learning–based Automatic Detection Algorithm for Reducing Overlooked Lung Cancers on Chest Radiographs
Chest radiograph interpretation, assisted by a deep learning–based automatic detection algorithm, can reduce the number of overlooked lung cancers without increasing the frequency of chest CT follo... Background It is uncertain whether a deep learning–based automatic detection algorithm (DLAD) for identifying malignant nodules on chest radiographs will help diagnose lung cancers. Purpose To eval...
- Open Access
- 1 January 2020
- Published by XMLink in Korean Journal of Radiology
- Vol. 21 (5) , 526-536
Usefulness of CT-Guided Percutaneous Transthoracic Needle Lung Biopsies in Patients with Suspected Pulmonary Infection
Kim J, et al. Korean J Radiol. 2020 Feb;21:e46. https://doi.org/10.3348/kjr.2019.0492
- 1 January 2020
- Published by XMLink in Korean Journal of Radiology
- Vol. 21 (5) , 526-536
Open AccessUsefulness of CT-Guided Percutaneous Transthoracic Needle Lung Biopsies in Patients with Suspected Pulmonary Infection
Kim J, et al. Korean J Radiol. 2020 Feb;21:e46. https://doi.org/10.3348/kjr.2019.0492
- 19 January 2016
- Published by Springer Nature in European Radiology
- Vol. 26 (10) , 3660-3668
Radiogenomic correlation in lung adenocarcinoma with epidermal growth factor receptor mutations: Imaging features and histological subtypes
Objectives To correlate imaging features of resected lung adenocarcinoma with epidermal growth factor receptor (EGFR) mutation and the IASLC/ATS/ERS classification histological subtypes. Methods In 250 consecutive patients with resected lung adenocarcinoma, EGFR mutation status was correlated with demographics, imaging features including ground-glass opacity (GGO) proportion and the IASLC/ATS/ERS classification histological subtypes. Results EGFR mutations were significantly more frequent in women (54.5 % vs. 38.1 %, p = 0.011) and in never-smokers (54.7 % vs. 35.3 %, p = 0.003). GGO proportion was significantly higher in tumours with EGFR mutation than in those without (30.3 ± 33.8 % vs. 19.0 ± 29.3 %, p = 0.005). EGFR mutation was significantly more frequent in tumours with GGO ≥ 50 % and tumours with any GGO (p = 0.026 and 0.008, respectively). Adenocarcinomas with exon 19 or 21 mutation showed significantly higher GGO proportion than that in EGFR wild-type tumours (p = 0.009 and 0.029, respectively). Absence of GGO was an independent predictor of negative EGFR mutation (odds ratio, 1.81; 95 % confidence interval, 1.16–3.04; p = 0.018). Conclusions GGO proportion in adenocarcinomas with EGFR mutation was significantly higher than that in EGFR wild-type tumours, and the absence of GGO on CT was an independent predictor of negative EGFR mutation. Key Points • Ground-glass opacity (GGO) proportion is significantly higher in EGFR-mutated adenocarcinomas • Exon 19 or 21 mutated adenocarcinomas shows significantly higher GGO proportion • GGO absence is an independent predictor of negative EGFR mutation in lung adenocarcinomas
- 19 January 2016
- Published by Springer Nature in European Radiology
- Vol. 26 (10) , 3660-3668
Radiogenomic correlation in lung adenocarcinoma with epidermal growth factor receptor mutations: Imaging features and histological subtypes
Objectives To correlate imaging features of resected lung adenocarcinoma with epidermal growth factor receptor (EGFR) mutation and the IASLC/ATS/ERS classification histological subtypes. Methods In 250 consecutive patients with resected lung adenocarcinoma, EGFR mutation status was correlated with demographics, imaging features including ground-glass opacity (GGO) proportion and the IASLC/ATS/ERS classification histological subtypes. Results EGFR mutations were significantly more frequent in women (54.5 % vs. 38.1 %, p = 0.011) and in never-smokers (54.7 % vs. 35.3 %, p = 0.003). GGO proportion was significantly higher in tumours with EGFR mutation than in those without (30.3 ± 33.8 % vs. 19.0 ± 29.3 %, p = 0.005). EGFR mutation was significantly more frequent in tumours with GGO ≥ 50 % and tumours with any GGO (p = 0.026 and 0.008, respectively). Adenocarcinomas with exon 19 or 21 mutation showed significantly higher GGO proportion than that in EGFR wild-type tumours (p = 0.009 and 0.029, respectively). Absence of GGO was an independent predictor of negative EGFR mutation (odds ratio, 1.81; 95 % confidence interval, 1.16–3.04; p = 0.018). Conclusions GGO proportion in adenocarcinomas with EGFR mutation was significantly higher than that in EGFR wild-type tumours, and the absence of GGO on CT was an independent predictor of negative EGFR mutation. Key Points • Ground-glass opacity (GGO) proportion is significantly higher in EGFR-mutated adenocarcinomas • Exon 19 or 21 mutated adenocarcinomas shows significantly higher GGO proportion • GGO absence is an independent predictor of negative EGFR mutation in lung adenocarcinomas